Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.

S. Luquero-Bueno (Madrid, Spain), J. Galván-Román (Madrid, Spain), J. Curbelo (Madrid, Spain), A. Lancho-Sánchez (Madrid, Spain), E. Roy-Vallejo (Madrid, Spain), M. Ortega-Gómez (Madrid, Spain), M. Gómez (Madrid, Spain), G. Mateo-Jimenez (Madrid, Spain), M. Manzaneque-Pradales (Madrid, Spain), J. Aspa Marco (Madrid, Spain)

Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Session: Prognosis in bacterial and viral pneumonia
Session type: Thematic Poster
Number: 4532
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Luquero-Bueno (Madrid, Spain), J. Galván-Román (Madrid, Spain), J. Curbelo (Madrid, Spain), A. Lancho-Sánchez (Madrid, Spain), E. Roy-Vallejo (Madrid, Spain), M. Ortega-Gómez (Madrid, Spain), M. Gómez (Madrid, Spain), G. Mateo-Jimenez (Madrid, Spain), M. Manzaneque-Pradales (Madrid, Spain), J. Aspa Marco (Madrid, Spain). Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.. 4532

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013



Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




Blood eosinophil count predicts severity of respiratory failure, death and future exacerbations in severe life-threatening asthma
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018



Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012



Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019



Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012



Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?
Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017
Year: 2017



Biomarkers and cardiovascular events in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016



Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007

Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011



Severe acute malnutrition(SAM) as a predictor of mortality in pediatric community acquired pneumonia
Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others
Year: 2019

Comunity acquired legionella pneumonia: cardiovascular events and survival
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020


Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia
Source: Eur Respir J 2009; 34: 932-939
Year: 2009



Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011